GYEMSZI - MOB

European Journal of Microbiology and Immunology - Kapcsolódó tételek

351.			Surveillance of enteropathogenic bacteria, protozoa and helminths in travellers returning from the tropics
352.			Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice
353.			Sustained TL1A (TNFSF15) expression on both lymphoid and myeloid cells leads to mild spontaneous intestinal inflammation and fibrosis
354.			Synergistic Antimicrobial Effects of Cefabronchin
355.			The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 ameliorates acute DSS colitis
356.			The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 promotes enzymatic activity of matrixmetalloproteinase-2 in vitro
357.			Taking stock of infections and antibiotic resistance in the elderly and long-term care facilities: A survey of existingand upcoming challenges
358.			Targeting antigens to DEC-205 on dendritic cells induces immune protection in experimental colitis in mice
359.			TFF Peptides Play a Role in the Immune Response Following Oral Infection of Mice with Toxoplasma gondii
360.			Therapeutic effects of oral benzoic acid application during acute murine campylobacteriosis
361.			Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii
362.			Tissue-specific induction of CCR6 and Nrp1 during early CD4+ T cell differentiation
363.			Toll-like receptor-4 dependent inflammatory responses following intestinal colonization of secondary abiotic IL10-deficient mice with multidrug-resistant Pseudomonas aeruginosa
364.			Toll-like receptor-4 dependent intestinal gene expression during Arcobacter butzleri infection of gnotobiotic IL-10 deficient mice
365.			Toll-like receptor-4 dependent small intestinal immune responses following murine Arcobacter butzleri infection
366.			Toll-like receptor-4 is essential for Arcobacter butzleri-induced colonic and systemic immune responses in gnotobiotic IL-10-/- mice
367.			Toxoplasma gondii exposure and neurological disorders: An age- and gender-matched case-control pilot study
368.			Toxoplasma Gondii Infection and a History of Surgery: A Case Control Seroprevalence Study
369.			Toxoplasma Gondii Infection and Depression: A Case-Control Seroprevalence Study
370.			Toxoplasma gondii infection and multiple sclerosis: An age- and a gender-matched case-control seroprevalence study
371.			Toxoplasma gondii infection of chicken embryos causes retinal changes and modulates HSP90B1 gene expression: A promising ocular toxoplasmosis model
372.			Toxoplasma gondii infection of the central nervous system and suicide: A case-control study of decedents
373.			Toxoplasma gondii seroprevalence and risk factors of cats in the Budapest area
374.			Tracheoesophageal fistula due to Candida and Actinomyces co-infection: A case report and comprehensive review of the literature
375.			Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18
376.			Trichomonas vaginalis Detection in Female Specimens with cobasW TV/MG for use on the cobasW 6800/8800 Systems
377.			True facets of TB diagnosis in 2012: Hypes and realities
378.			Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment
379.			Tuberculosis in adolescents and young patients in high prevalence region
380.			Tuberculosis surveillance and control in Germany : an application of the Berlin Declaration Monitoring and Evaluation Framework
381.			Usage of murine T-cell hybridoma cells as responder cells reveals interference of Helicobacter pylori with human dendritic cell-mediated antigen presentation
382.			Validation of the Cepheid Xpert(R) Xpress SARS-CoV-2 using upper and lower respiratory tract specimens
383.			Very low prevalence of Mansonella perstans-specific cell-free DNA in serum samples of Ghanaian HIV patients
384.			Virulence genes in a probiotic E. coli product with a recorded long history of safe use
385.			Vitamin E as promising adjunct treatment option in the combat of infectious diseases caused by bacterial including multi-drug resistant pathogens - Results from a comprehensive literature survey
386.			What you eat is what you get: novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection
387.			Worldwide Protein Data Bank (wwPDB): A virtual treasure for research in biotechnology
388.			X-linked severe combined immunodeficiency due to a novel mutation complicated with hemophagocytic lymphohistiocytosis and presented with invagination: a case report
389.			Yersinia Pseudotuberculosis Modulates Regulatory T Cell Stability via Injection of Yersinia Outer Proteins in a Type III Secretion System-Dependent Manner
390.			ß-lactamases encoded by blaCTX-M group I genes as determinants of resistance of ESBL-positive enterobacteriaceae in European soldiers in tropical Mali

Mind kijelölve: